MedPath

A study to compare the efficacy of sarivadi kashaya and parpatadi kashaya as gudavarti(suppository) in jwara santapa(pyrexia) in childre

Phase 3
Conditions
Health Condition 1: 3- Administration
Registration Number
CTRI/2024/07/070206
Lead Sponsor
Dr Parvathy B Geethakumar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Subjects with pyrexia with an axillary temperature ranging from 99.80°F to 103.0°F (low to moderate pyrexia). Subjects in whom parents are willing to sign the written consent form will be included.

Exclusion Criteria

Subjects who present with high-grade fever and subjects with a history of febrile seizures, epilepsy, or meningitis.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Significant decrease in Jwara santapa (pyrexia) assessed based on GRASP fever chart.Timepoint: At 0-30 minutes,60 minutes,120minutes and 180 minutes after administration of gudavarti.
Secondary Outcome Measures
NameTimeMethod
Generation of in - depth analysed data on the different aspect of the disease- Jwara & generation of data on possible unexpected drug reactions which might occur during the study duration. <br/ ><br>Timepoint: 3 hours
© Copyright 2025. All Rights Reserved by MedPath